Correlation Between Fortress Biotech and Regen BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fortress Biotech and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fortress Biotech and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fortress Biotech Pref and Regen BioPharma, you can compare the effects of market volatilities on Fortress Biotech and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fortress Biotech with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fortress Biotech and Regen BioPharma.

Diversification Opportunities for Fortress Biotech and Regen BioPharma

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between Fortress and Regen is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Fortress Biotech Pref and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and Fortress Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fortress Biotech Pref are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of Fortress Biotech i.e., Fortress Biotech and Regen BioPharma go up and down completely randomly.

Pair Corralation between Fortress Biotech and Regen BioPharma

Assuming the 90 days horizon Fortress Biotech Pref is expected to under-perform the Regen BioPharma. But the preferred stock apears to be less risky and, when comparing its historical volatility, Fortress Biotech Pref is 5.1 times less risky than Regen BioPharma. The preferred stock trades about -0.02 of its potential returns per unit of risk. The Regen BioPharma is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  5.20  in Regen BioPharma on December 30, 2024 and sell it today you would lose (0.09) from holding Regen BioPharma or give up 1.73% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy96.88%
ValuesDaily Returns

Fortress Biotech Pref  vs.  Regen BioPharma

 Performance 
       Timeline  
Fortress Biotech Pref 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Fortress Biotech Pref has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Fortress Biotech is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Regen BioPharma 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.

Fortress Biotech and Regen BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fortress Biotech and Regen BioPharma

The main advantage of trading using opposite Fortress Biotech and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fortress Biotech position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.
The idea behind Fortress Biotech Pref and Regen BioPharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing